| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Vaxart, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Di | Vaxart, Inc.: Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers | 151 | GlobeNewswire (Europe) | Antibody rise observed in lactating mothers and in their breast milk Long-term goal is to provide protection to infants through passive antibody transfer SOUTH SAN FRANCISCO, Calif., April 30, 2024... ► Artikel lesen | |
| 27.03. | Vaxart, Inc.: Vaxart to Present at World Vaccine Congress Washington 2024 on April 3 | 9 | GlobeNewswire (USA) | ||
| 20.03. | Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 149 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the"Company"or"Vaxart") today announced that the Compensation Committee of the Board of Directors approved... ► Artikel lesen | |
| 15.03. | Earnings call: Vaxart reports progress in oral vaccine development | 10 | Investing.com | ||
| 14.03. | Vaxart Inc reports results for the quarter ended in December - Earnings Summary | 7 | Reuters | ||
| 14.03. | Vaxart, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 14.03. | Vaxart, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
| 14.03. | Recap: Vaxart Q4 Earnings | 4 | Benzinga.com | ||
| 14.03. | Vaxart, Inc.: Vaxart Provides Business Update and Reports Full Year 2023 Financial Results | 463 | GlobeNewswire (Europe) | Significant progress made in preparing for a Phase 2b study evaluating Vaxart's oral pill XBB COVID-19 vaccine against an approved mRNA vaccine comparator Topline data from Phase 1 norovirus study... ► Artikel lesen | |
| 14.03. | Vaxart, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 13.03. | Vaxart FY 2023 Earnings Preview | 7 | Seeking Alpha | ||
| 13.03. | Vaxart's Earnings: A Preview | 7 | Benzinga.com | ||
| 07.03. | Vaxart, Inc.: Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14 | 5 | GlobeNewswire (USA) | ||
| 06.03. | Vaxart appoints Steven Lo as president, CEO, and director | 1 | Seeking Alpha | ||
| 06.03. | Vaxart appoints Steven Lo as new President and CEO | 2 | Investing.com | ||
| 06.03. | Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director | 107 | GlobeNewswire (Europe) | Michael J. Finney, Ph.D. to Continue as Chairman of the Board of Directors SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart")... ► Artikel lesen | |
| 29.02. | Vaxart, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.02. | Vaxart, Inc. - 8-K, Current Report | 12 | SEC Filings | ||
| 05.02. | Vaxart, Inc.: Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge | 251 | GlobeNewswire (Europe) | - Data served as foundation for current vaccine candidate for planned Phase 2 research - Vaxart vaccine candidates elicited strong antigen-specific serum IgG and IgA with neutralizing activity against... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 335 |
| BAYER | 211 |
| BYD | 202 |
| NVIDIA | 187 |
| NEL | 176 |
| PLUG POWER | 170 |
| TESLA | 164 |
| SUPER MICRO COMPUTER | 162 |
| APPLE | 154 |
| TUI | 154 |
| DEUTSCHE BANK | 142 |
| RHEINMETALL | 129 |
| AMAZON | 125 |
| RWE | 115 |
| DEUTSCHE LUFTHANSA | 113 |
| MERCEDES-BENZ | 110 |
| BERKSHIRE HATHAWAY | 104 |
| PAYPAL | 101 |
| BIONTECH | 98 |
| COMMERZBANK | 97 |
| ALLIANZ | 95 |
| RENK GROUP | 95 |
| CUREVAC | 90 |
| MICROSOFT | 86 |
| AIXTRON SE | 82 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
